143 related articles for article (PubMed ID: 33811313)
1. Durable response after discontinuation of pembrolizumab therapy for intrahepatic cholangiocarcinoma: a case report.
Eguchi S; Shinkawa H; Sato Y; Nakai K; Takemura S; Tanaka S; Amano R; Kimura K; Ohira G; Nishio K; Kinoshita M; Tauchi J; Miyazaki T; Ishihara A; Shirai D; Kubo S
Clin J Gastroenterol; 2021 Jun; 14(3):858-865. PubMed ID: 33811313
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite Instability-high Intrahepatic Cholangiocarcinoma with Portal Vein Tumor Thrombosis Successfully Treated with Pembrolizumab.
Naganuma A; Sakuda T; Murakami T; Aihara K; Watanuki Y; Suzuki Y; Shibasaki E; Masuda T; Uehara S; Yasuoka H; Hoshino T; Kudo T; Ishihara H; Ogawa T; Kitamoto Y; Ogawa A
Intern Med; 2020 Sep; 59(18):2261-2267. PubMed ID: 32536644
[TBL] [Abstract][Full Text] [Related]
3. Effective Response of Intrahepatic Cholangiocarcinoma to Pembrolizumab: A Case Report.
Nakamura M; Ueno M; Hayami S; Kawai M; Miyamoto A; Suzaki N; Hirono S; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Kojima F; Yamaue H
Anticancer Res; 2020 Jul; 40(7):4123-4129. PubMed ID: 32620661
[TBL] [Abstract][Full Text] [Related]
4. Intrahepatic Cholangiocarcinoma with High Microsatellite Instability and Tumor Mutation Burden That Responded Significantly to Pembrolizumab but Perforated within a Short Period.
Yamazaki S; Kubota K; Shimizu A; Notake T; Umemura K; Kamachi A; Goto T; Tomida H; Yamashita N; Sato M; Kanno H; Soejima Y
Intern Med; 2024 Apr; 63(8):1105-1112. PubMed ID: 37779076
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of pembrolizumab in microsatellite instability-high locally advanced cholangiocarcinoma: a case report.
Toshida K; Itoh S; Yoshizumi T; Shimagaki T; Wang H; Kurihara T; Toshima T; Nagao Y; Harada N; Oki E; Nakamura Y; Yoshino T; Mori M
Clin J Gastroenterol; 2021 Oct; 14(5):1459-1463. PubMed ID: 34085164
[TBL] [Abstract][Full Text] [Related]
6. [A Case of TMB-High Recurrent Peritoneal Seeding in Hilar Cholangiocarcinoma Treated with Pembrolizumab Therapy].
Shinke G; Takeda Y; Ohmura Y; Kinoshita M; Katsura Y; Aoyama S; Kihara Y; Yanagisawa K; Katsuyama S; Ikeshima R; Hiraki M; Sugimura K; Masuzawa T; Hata T; Murata K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1875-1877. PubMed ID: 38303237
[TBL] [Abstract][Full Text] [Related]
7. Significant response to anti-PD-1 based immunotherapy plus lenvatinib for recurrent intrahepatic cholangiocarcinoma with bone metastasis: A case report and literature review.
Chen WX; Li GX; Hu ZN; Zhu P; Zhang BX; Ding ZY
Medicine (Baltimore); 2019 Nov; 98(45):e17832. PubMed ID: 31702638
[TBL] [Abstract][Full Text] [Related]
8. A metastatic intrahepatic cholangiocarcinoma treated with programmed cell death 1 inhibitor: a case report and literature review.
Zhang J; Wu L; Liu J; Lin M
Immunotherapy; 2020 Jun; 12(8):555-561. PubMed ID: 32372672
[TBL] [Abstract][Full Text] [Related]
9. [A case of unresectable intrahepatic cholangiocarcinoma receiving sustainable pembrolizumab therapy].
Matsushita S; Ueo T; Minami R; Ozawa T; Matsumoto A; Kimura Y; Takeda Y; Okano A; Kusumi F; Ohana M
Nihon Shokakibyo Gakkai Zasshi; 2022; 119(4):360-367. PubMed ID: 35400689
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
[TBL] [Abstract][Full Text] [Related]
11. Application of Immune Checkpoint Inhibitors in the Treatment of Cholangiocarcinoma.
Zeng FL; Chen JF
Technol Cancer Res Treat; 2021; 20():15330338211039952. PubMed ID: 34528830
[TBL] [Abstract][Full Text] [Related]
12. Durable response with lenvatinib and pembrolizumab combination therapy in a patient with pre-treated metastatic cholangiocarcinoma.
Dreikhausen L; Kusnik A; Schulte N; Eckardt M; Teufel A; Gaiser T; Ebert M; Zhan T
J Gastrointestin Liver Dis; 2021 Sep; 30(3):409-410. PubMed ID: 34551034
[No Abstract] [Full Text] [Related]
13. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Roncati L
Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
[TBL] [Abstract][Full Text] [Related]
14. Clinical response to adding pyrotinib to pembrolizumab and lenvatinib for HER2-positive advanced intrahepatic cholangiocarcinoma: a case report.
Zhang JW; Yang X; Pan B; Xu Y; Lu X; Zhao HT
World J Surg Oncol; 2023 Mar; 21(1):108. PubMed ID: 36973682
[TBL] [Abstract][Full Text] [Related]
15. Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer.
Czink E; Kloor M; Goeppert B; Fröhling S; Uhrig S; Weber TF; Meinel J; Sutter C; Weiss KH; Schirmacher P; Doeberitz MVK; Jäger D; Springfeld C
Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28619747
[TBL] [Abstract][Full Text] [Related]
16. Successful Treatment of Advanced Intrahepatic Cholangiocarcinoma With a High Tumor Mutational Burden and PD-L1 Expression by PD-1 Blockade Combined With Tyrosine Kinase Inhibitors: A Case Report.
Zhang Z; Zhang W; Wang H; Hu B; Wang Z; Lu S
Front Immunol; 2021; 12():744571. PubMed ID: 34603331
[TBL] [Abstract][Full Text] [Related]
17. Significant response to pembrolizumab plus lenvatinib in Epstein-Barr-virus-associated intrahepatic cholangiocarcinoma: a case report.
Li L; Yu D; Yang J; Zhang F; Zhang D; Lin Z; Zhai M; Wang J; Zhang T; Zhao L
Cancer Biol Ther; 2024 Dec; 25(1):2338644. PubMed ID: 38650446
[TBL] [Abstract][Full Text] [Related]
18. PD-1 Inhibitors Plus Capecitabine as Maintenance Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Case Report and Review of Literature.
Wang Z; Zeng T; Li Y; Zhang D; Yuan Z; Huang M; Yang Y; Zhou W
Front Immunol; 2021; 12():799822. PubMed ID: 35003124
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis.
Asakura H; Ohtsuka M; Ito H; Kimura F; Ambiru S; Shimizu H; Togawa A; Yoshidome H; Kato A; Miyazaki M
Hepatogastroenterology; 2005; 52(63):722-4. PubMed ID: 15966191
[TBL] [Abstract][Full Text] [Related]
20. [A case report of combined hepatocellular-cholangiocarcinoma whose lymph node recurrence effectively treated with UFT].
Shimizu J; Hayashi S; Dono K; Yasumoto T; Zenitani M; Munakata K; Watanabe N; Takamoto K; Kagawa Y; Hata T; Kawanishi K; Ikeda K; Fujita J; Akagi K; Kitada M; Shimano T
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2380-2. PubMed ID: 20037429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]